244 related articles for article (PubMed ID: 30336492)
1. Glutamate-Related Antibodies and Peripheral Insulin-Like Growth Factor in Bipolar Disorder and Lithium Prophylaxis.
Ferensztajn-Rochowiak E; Kaczmarek M; Wójcicka M; Kaufman-Szukalska E; Dziuda S; Remlinger-Molenda A; Szeliga-Neymann A; Losy J; Rybakowski JK
Neuropsychobiology; 2019; 77(1):49-56. PubMed ID: 30336492
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.
Pearlman DM; Najjar S
Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
4. Lower serum insulin-like growth factor 2 level in patients with bipolar disorder is associated with the severity of manic symptoms during manic episodes.
Ye SY; Zhao Y; Liu ZB; Luo CP; Xiong JW; Zhan JQ; Li YH; Wei B; Chen CN; Yang YJ
Front Psychiatry; 2024; 15():1354999. PubMed ID: 38563028
[TBL] [Abstract][Full Text] [Related]
5. [Activity of selected cytokines in bipolar patients during manic and depressive episodes].
Remlinger-Molenda A; Wójciak P; Michalak M; Rybakowski J
Psychiatr Pol; 2012; 46(4):599-611. PubMed ID: 23214162
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of plasma agmatine level and its metabolic pathway in patients with bipolar disorder during manic episode and remission period.
Yılmaz E; Şekeroğlu MR; Yılmaz E; Çokluk E
Int J Psychiatry Clin Pract; 2019 Jun; 23(2):128-133. PubMed ID: 31081413
[No Abstract] [Full Text] [Related]
7. Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.
León-Caballero J; Pacchiarotti I; Murru A; Valentí M; Colom F; Benach B; Pérez V; Dalmau J; Vieta E
Neurosci Biobehav Rev; 2015 Aug; 55():403-12. PubMed ID: 26014349
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder.
Liu X; Zhang T; He S; Hong B; Chen Z; Peng D; Wu Y; Wen H; Lin Z; Fang Y; Jiang K
Psychiatry Res; 2014 Aug; 218(1-2):54-60. PubMed ID: 24793757
[TBL] [Abstract][Full Text] [Related]
9. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
[TBL] [Abstract][Full Text] [Related]
10. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
Tohen M; Wang WV; Leboyer M; Jen KY
J Clin Psychiatry; 2012 Jul; 73(7):e913-7. PubMed ID: 22901362
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium.
Muti M; Del Grande C; Musetti L; Marazziti D; Turri M; Cirronis M; Pergentini I; Corsi M; Dell'Osso L; Corsini GU
Psychiatry Res; 2015 Feb; 225(3):604-8. PubMed ID: 25547850
[TBL] [Abstract][Full Text] [Related]
12. Electrodermal activity in bipolar disorder: Differences between mood episodes and clinical remission using a wearable device in a real-world clinical setting.
Anmella G; Mas A; Sanabra M; Valenzuela-Pascual C; Valentí M; Pacchiarotti I; Benabarre A; Grande I; De Prisco M; Oliva V; Fico G; Giménez-Palomo A; Bastidas A; Agasi I; Young AH; Garriga M; Corponi F; Li BM; de Looff P; Vieta E; Hidalgo-Mazzei D
J Affect Disord; 2024 Jan; 345():43-50. PubMed ID: 37865347
[TBL] [Abstract][Full Text] [Related]
13. Exploring the relationship between vitamin D and mania: correlations between serum vitamin D levels and disease activity.
Altunsoy N; Yüksel RN; Cingi Yirun M; Kılıçarslan A; Aydemir Ç
Nord J Psychiatry; 2018 Apr; 72(3):221-225. PubMed ID: 29308715
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.
Squassina A; Costa M; Congiu D; Manchia M; Angius A; Deiana V; Ardau R; Chillotti C; Severino G; Calza S; Del Zompo M
Pharmacol Res; 2013 Jul; 73():1-7. PubMed ID: 23619527
[TBL] [Abstract][Full Text] [Related]
15. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
Geoffroy PA; Bellivier F; Henry C
Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
[TBL] [Abstract][Full Text] [Related]
17. Increased uric acid levels in bipolar disorder: is it trait or state?
Kesebir S; Süner O; Yaylaci ET; Bayrak A; Turan C
J Biol Regul Homeost Agents; 2013; 27(4):981-8. PubMed ID: 24382179
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum zinc concentration during depressive episode in patients with bipolar disorder.
Siwek M; Sowa-Kućma M; Styczeń K; Szewczyk B; Reczyński W; Misztak P; Topór-Mądry R; Nowak G; Dudek D; Rybakowski JK
J Affect Disord; 2016 Jan; 190():272-277. PubMed ID: 26540081
[TBL] [Abstract][Full Text] [Related]
19. May oxytocin be a trait marker for bipolar disorder?
Turan T; Uysal C; Asdemir A; Kılıç E
Psychoneuroendocrinology; 2013 Dec; 38(12):2890-6. PubMed ID: 24080188
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
Kunz M; Gama CS; Andreazza AC; Salvador M; Ceresér KM; Gomes FA; Belmonte-de-Abreu PS; Berk M; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1677-81. PubMed ID: 18657586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
